Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC).

MLA

Harewood, Rhea, et al. “Association between Pre-Diagnostic Circulating Lipid Metabolites and Colorectal Cancer Risk: A Nested Case-Control Study in the European Prospective Investigation into Cancer and Nutrition (EPIC).” EBioMedicine, vol. 101, Mar. 2024, p. 105024. EBSCOhost, https://doi.org/10.1016/j.ebiom.2024.105024.

APA

Harewood, R., Rothwell, J. A., Bešević, J., Viallon, V., Achaintre, D., Gicquiau, A., Rinaldi, S., Wedekind, R., Prehn, C., Adamski, J., Schmidt, J. A., Jacobs, I., Tjønneland, A., Olsen, A., Severi, G., Kaaks, R., Katzke, V., Schulze, M. B., Prada, M., … Gunter, M. J. (2024). Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC). EBioMedicine, 101, 105024. https://doi.org/10.1016/j.ebiom.2024.105024

Chicago

Harewood, Rhea, Joseph A Rothwell, Jelena Bešević, Vivian Viallon, David Achaintre, Audrey Gicquiau, Sabina Rinaldi, et al. 2024. “Association between Pre-Diagnostic Circulating Lipid Metabolites and Colorectal Cancer Risk: A Nested Case-Control Study in the European Prospective Investigation into Cancer and Nutrition (EPIC).” EBioMedicine 101 (March): 105024. doi:10.1016/j.ebiom.2024.105024.